Pharmaceutical Chemistry Journal

, Volume 26, Issue 11–12, pp 906–909 | Cite as

Modification of the method of gas chromatographic determination of sodium hydroxy-butyrate in biomaterial

  • A. K. Sariev
  • V. S. Kozyar
  • V. P. Zherdev
  • R. U. Ostrovskaya
Studies of the Structures of Chemical Compounds, Methods of Analysis and Production Monitoring


Sodium Organic Chemistry Chromatographic Determination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    N. N. Dement'eva, M. I. Kuleshova, and O. D. Kolyutskaya, Farmatsiya,19, No. 6, 66–70 (1970).Google Scholar
  2. 2.
    A. F. Lopatin, Farmakol. Toksikol., No. 5, 53–56 (1984).Google Scholar
  3. 3.
    M. D. Mashkovskii, Drugs [in Russian], 11th edn., Vol. 1, Meditsina, Moscow (1988).Google Scholar
  4. 4.
    N. G. Ninua, O. Sh. Samushiya, Some Problems of the Treatment of Hypoxic State of the Brain with Sodium Hydroxybutyrate, Problems of Modern Neurology [in Russian], Tbilisi (1985), pp. 190–199.Google Scholar
  5. 5.
    A. L. Pertsovskii, Byull. Éksp. Biol. Med., No. 1, 434–436 (1977).Google Scholar
  6. 6.
    F. Depaulis, J. J. Bourguignon, C. Marescaux, et al., Neuropharmacology,27, No. 7, 683–689 (1988).Google Scholar
  7. 7.
    J. D. Doherty, S. E. Hattox, O. C. Snead, and R. H. Poth, J. Pharmacol. Exp. Ther.,207, 120–139 (1978).Google Scholar
  8. 8.
    J. T. Lettieri and Ho-L. Fung, Biochem. Med.,20, 70–80 (1978).Google Scholar
  9. 9.
    J. T. Lettieri and Ho-L. Fung, J. Pharmacol. Exp. Ther.,208, No. 1, 7–11 (1979).Google Scholar
  10. 10.
    W. van der Pol, E. van der Kleijn, and M. Lauw, J. Pharmacokin. Biopharm.,3, No. 2, 99–113 (1975).Google Scholar
  11. 11.
    R. H. Roth and N. J. Giarman, Biochem. Pharmacol.,18, 247–250 (1969).Google Scholar
  12. 12.
    J. S. Shumate and O. C. Snead, Res. Commun. Chem. Path. Pharm.,25, No. 2, 241–262 (1979).Google Scholar
  13. 13.
    O. C. Snead, Neurology,28, No. 7, 636–642 (1978).Google Scholar
  14. 14.
    O. C. Snead, L. J. Bearden, and V. Pegram, Neuropharmacology,19, 47–52 (1980).Google Scholar
  15. 15.
    O. C. Snead, G. B. Brown, and R. B. Morawetz, New Engl. J. Of Med.,304, 93–95 (1981).Google Scholar
  16. 16.
    O. C. Snead, Brain Res.,543, 10–14 (1991).Google Scholar
  17. 17.
    O. C. Snead, Neuropharmacology,30, No. 2, 161–167 (1991).Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • A. K. Sariev
    • 1
  • V. S. Kozyar
    • 1
  • V. P. Zherdev
    • 1
  • R. U. Ostrovskaya
    • 1
  1. 1.Scientific-Research Institute of PharmacologyRussian Academy of Medical SciencesMoscow

Personalised recommendations